Status:
COMPLETED
Osteopontin in Metastatic Breast Cancer Patients
Lead Sponsor:
Mansoura University
Conditions:
Survival, Prosthesis
Eligibility:
FEMALE
31-74 years
Brief Summary
OPN plays an important role in various aspects of malignancy, particularly those involved in tissue invasion and metastasis, and OPN levels have been associated with aggressive¬ness in several cancer ...
Detailed Description
Analysis of polymorphisms in the OPN regulatory region: The PCR amplification of the promoter regulatory region from the extracted DNA by using the following primers -3 (forward primer 5" -CAA GCT AC...
Eligibility Criteria
Inclusion
- de novo metastatic breast cancer patients recruited from Oncology center Mansoura University and clinical oncology department, Mansoura University Hospital All included patients were presented with disseminated visceral +/- bone metastasis (visceral crisis)
Exclusion
- brain metastasis was excluded
Key Trial Info
Start Date :
January 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2019
Estimated Enrollment :
119 Patients enrolled
Trial Details
Trial ID
NCT04274504
Start Date
January 1 2015
End Date
November 1 2019
Last Update
February 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura University Oncology Center
Al Mansurah, Dakahlia Governorate, Egypt, 35516